Brian Lenz
2019 - ADMA Biologics
In 2019, Brian Lenz earned a total compensation of $1.1M as Executive Vice President and Chief Financial Officer at ADMA Biologics, a 19% increase compared to previous year.
Compensation breakdown
| Bonus | $195,000 |
|---|---|
| Option Awards | $380,429 |
| Salary | $390,000 |
| Other | $156,725 |
| Total | $1,122,154 |
Lenz received $390K in salary, accounting for 35% of the total pay in 2019.
Lenz also received $195K in bonus, $380.4K in option awards and $156.7K in other compensation.
Rankings
In 2019, Brian Lenz's compensation ranked 8,743rd out of 13,971 executives tracked by ExecPay. In other words, Lenz earned more than 37.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,743 out of 13,971 | 37th |
Division Manufacturing | 3,483 out of 5,701 | 39th |
Major group Chemicals And Allied Products | 1,316 out of 2,200 | 40th |
Industry group Drugs | 1,120 out of 1,886 | 41st |
Industry Biological Products, Except Diagnostic Substances | 252 out of 389 | 35th |
Source: SEC filing on April 29, 2020.
Lenz's colleagues
We found two more compensation records of executives who worked with Brian Lenz at ADMA Biologics in 2019.
News
ADMA Biologics CEO Adam Grossman's 2023 pay jumps 128% to $6M
April 15, 2024
ADMA Biologics CEO Adam Grossman's 2022 pay falls 39% to $2.6M
April 13, 2023
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019